relocation may give rise to the duplicated cost of labor between the factory at Laem Chabang and the new factory at Amata City to incur. In addition, during such period, the new factory was in the early stage
Limited (the “Company”) would like to inform you of the operating results for the year 2018, ended 31 December 2018, audited by the Company’s external auditor, reviewed by the Audit Committee at the meeting
Custom Design power supplies also steadily growth at 7.6% and 6.0% respectively Sales revenues breakdown by geographic location In 2018, sales revenues in Asia market represents the highest proportion, 46
wishes to hereby report to the SET the resolution earlier adopted at its Board of Directors’ meeting no. 7/2018 on February 21, 2019. Said resolution authorized the company to enter into transaction to
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
-term employment benefits of 400 days scheme at 6.20 million Baht and the production capacity is not full efficiency, as resulted decrease in gross profit margin from 7.65 percent for the year of 2018 to
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company
the year-ended 31 December 2019 was 308.8 million baht compared to consolidated net loss attributable to equity holders of the Company at 167.7 million baht the same period last year, increased 141.1
2019 ended at 31 December 2019 was 12,301,694 baht compared to the same period of 2018 at 13,928,718 baht, decreased 1,627,024 baht or 11.68%. While total assets and shareholders’ equity at the end of
34.33 million baht from surplus on land revaluation. -2- Balance Sheet - Total assets at December 31, 2019 was 848.42 million baht compared to December 31, 2018 which was 776.72 million baht. Because the